Should Antipsychotics' Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults' Behavioral Symptoms in Short-Staffed Units?
Journal
AMA journal of ethics
ISSN: 2376-6980
Titre abrégé: AMA J Ethics
Pays: United States
ID NLM: 101649265
Informations de publication
Date de publication:
01 10 2023
01 10 2023
Historique:
medline:
1
11
2023
pubmed:
6
10
2023
entrez:
6
10
2023
Statut:
epublish
Résumé
This commentary on a case considers risks and benefits of pharmacological and nonpharmacological management of agitation in patients with dementia. Specifically, it considers beneficence and nonmaleficence in treatment decisions that affect both patients and staff as well as autonomy and surrogate decision making.
Identifiants
pubmed: 37801055
pii: amajethics.2023.725
doi: 10.1001/amajethics.2023.725
doi:
pii:
Substances chimiques
Antipsychotic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E725-732Informations de copyright
Copyright 2023 American Medical Association. All Rights Reserved.